Notice 13 May 2025 chemical industry, taxation, irs, business implications, regulatory compliance, di-isodecyl phthalate

⚖️Notice on Tax Modification for Di-Isodecyl Phthalate by IRS

This notice of filing announces that a petition has been filed requesting that di-isodecyl phthalate be added to the list of taxable substances. This notice of filing also requests comments on the petition. This notice of filing is not a determination that the list of taxable substances is modified.

Learn More
Notice 13 May 2025 inflation reduction act, information collection, drug pricing, centers for medicare and medicaid services, regulatory compliance

💊Comment Request on Drug Pricing Collection by CMS

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

Learn More
Notice 13 May 2025 butyl rubber, irs, excise tax, superfund tax, regulatory compliance, chemical substances

⚛️IRS Notice on Superfund Tax for Regular Butyl Rubber Filing

This notice of filing announces that a petition has been filed requesting that regular butyl rubber ((C<INF>4</INF>H<INF>8</INF>)<INF>x</INF>(C<INF>5</INF>H<INF>8</INF>)<INF>y</INF> ; x = 7036, y = 88)) be added to the list of taxable substances. This notice of filing also requests comments on the petition. This notice of filing is not a determination that the list of taxable substances is modified.

Learn More
Notice 13 May 2025 advisory board, environmental management, waste management, public participation, meeting, regulatory compliance, cleanup

📅Notice of Meeting for Environmental Management Advisory Board

This notice announces an in-person/virtual meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Paducah. The Federal Advisory Committee Act requires that public notice of this meeting be announced in the Federal Register.

Learn More
Notice 13 May 2025 internal revenue service, neo pentanoic acid, business taxes, superfund tax, regulatory compliance, chemical substances

🧪Notice on Superfund Tax for Neo Pentanoic Acid Filing

This notice of filing announces that a petition has been filed requesting that neo pentanoic acid be added to the list of taxable substances. This notice of filing also requests comments on the petition. This notice of filing is not a determination that the list of taxable substances is modified.

Learn More
Notice 13 May 2025 bromobutyl rubber, taxation, irs, superfund tax, regulatory compliance, chemical substances

🧪Notice on Superfund Tax for Bromobutyl Isobutylene Rubber

This notice of filing announces that a petition has been filed requesting that bromobutyl isobutylene isoprene rubber ((C<INF>4</INF>H<INF>8</INF>)<INF>x</INF>(C<INF>5</INF>H<INF>8</INF>)<INF>y</INF> (Br<INF>2</INF>)<INF>z</INF>; x = 7071, y = 59, z = 50), also known as BIIR, be added to the list of taxable substances. This notice of filing also requests comments on the petition. This notice of filing is not a determination that the list of taxable substances is modified.

Learn More
Notice 12 May 2025 finance, regulatory compliance, legal services, line of credit, board meetings

🏦Update on Legal Services Corporation's Sunshine Act Meeting

The Legal Services Corporation announced changes to its Sunshine Act meeting, closing part of the session to discuss internal activities and a resolution regarding the corporation's line of credit agreement. The meeting emphasizes transparency and governance within the organization while addressing financial matters that could impact operations and funding.

Learn More
Notice 12 May 2025 finance, regulatory compliance, technology adoption, digitalization, community banks

💻OCC's Request for Information on Community Bank Digitalization

To build on its understanding, OCC is issuing a request for information (RFI) on community bank engagement with digitalization. The RFI solicits comment on the key challenges and barriers faced by community banks in the adoption and implementation of digital banking solutions.

Learn More
Notice 12 May 2025 public comments, information collection, regulatory compliance, veterans affairs

📄VA Notice on Application Request to Add/Remove Dependents

Veterans Benefits Administration (VBA), Department of Veterans Affairs (VA), is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act (PRA) of 1995, Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed revision of a currently approved collection, and allow 60 days for public comment in response to the notice.

Learn More
Notice 12 May 2025 ngenla, health products, patent extension, regulatory compliance, fda, pharmaceutical

💊FDA Notice on NGENLA Regulatory Review Period and Patent Extension

The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for NGENLA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.

Learn More